Investors could be disappointed with no sale of the company, but the review had dragged on with no news and this end of it really shouldn't be a big surprise. EPS of 12c beat estimates of 8.6c. Revenue of $678.2M beat estimates by 8%. EBITDA of $41M beat by 1%. CTS also declared its first dividend (1c). It also announced a CFO. Sales rose 23%, EBITDA rose 39%. Costs rose, but cash generation was good. EPS is expected to rise 60%+ over the next two years. Investors should be OK with these results and the new dividend to offset no sale of the company.
5i Research Answer: